Cayuela J M, Gardie B, Sigaux F
Laboratory of Molecular Hematology, Institut National de la Santé et de la Recherche Médicale (INSERM) U462, Centre Hayem, Hôpital Saint Louis, Paris, France.
Blood. 1997 Nov 1;90(9):3720-6.
We have recently shown that the multiple tumor suppressor gene 1 (MTS1 ) encoding the p16(INK4a) and p19(ARF) cell-cycle inhibitors is inactivated by deletion or disruption in most human T-cell acute lymphoblastic leukemias (T-ALLs), representing the most frequent genetic event thus far described in this disease. To analyze the mechanism of these chromosomal events, we used cloning, sequencing, and/or polymerase chain reaction mapping to study 15 rearrangements occurring in the MTS1 locus. We found that these breakpoints occur in two clusters (MTS1(bcralpha) and MTS1(bcrbeta) ). The three rearrangements occurring in MTS1(bcralpha) correspond to a recurrent recombination juxtaposing 5' MTS2 exon 1 and 5' MTS1 exon 1alpha sequences. Breakpoints for 10 of 12 rearrangements within MTS1(bcrbeta) are located at a polymorphic (CA) repeat, suggesting that this sequence might play a role in the clustering. For both MTS1(bcralpha) and MTS1(bcrbeta), sequence analyses and PCR mapping experiments show that the tightly clustered breakpoints are located in the vicinity of heptamers whose sequence is similar to those involved in the V(D)J recombination. Moreover, short deletions, GC-rich random nucleotide additions, and clone-specific junctional sequences are present in all cases, further suggesting that the rearrangements are due to illegitimate V(D)J recombinase activity. These data are the first demonstration that a tumor suppressor gene can be inactivated by the V(D)J recombinational mechanism. Moreover, they reinforce the view that this process, normally required for T-cell differentiation, plays a crucial role in the pathogenesis of T-ALL.
我们最近发现,编码p16(INK4a)和p19(ARF)细胞周期抑制剂的多肿瘤抑制基因1(MTS1)在大多数人类T细胞急性淋巴细胞白血病(T-ALL)中通过缺失或破坏而失活,这是迄今为止该疾病中描述的最常见的遗传事件。为了分析这些染色体事件的机制,我们使用克隆、测序和/或聚合酶链反应图谱来研究MTS1基因座中发生的15种重排。我们发现这些断点出现在两个簇中(MTS1(bcralpha)和MTS1(bcrbeta))。发生在MTS1(bcralpha)中的三种重排对应于一种反复出现的重组,将5'MTS2外显子1和5'MTS1外显子1alpha序列并列在一起。MTS1(bcrbeta)内12种重排中的10种断点位于一个多态性(CA)重复序列处,表明该序列可能在聚类中起作用。对于MTS1(bcralpha)和MTS1(bcrbeta),序列分析和PCR图谱实验表明,紧密聚类的断点位于七聚体附近,其序列与参与V(D)J重组的序列相似。此外,在所有情况下都存在短缺失、富含GC的随机核苷酸添加和克隆特异性连接序列,进一步表明这些重排是由于非法的V(D)J重组酶活性所致。这些数据首次证明了肿瘤抑制基因可以通过V(D)J重组机制失活。此外,它们强化了这样一种观点,即这个通常是T细胞分化所必需的过程在T-ALL的发病机制中起关键作用。